Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Spit test could predict prostate cancer risk in men of all backgrounds

NCT ID NCT06636526

First seen Feb 04, 2026 · Last updated May 23, 2026 · Updated 16 times

Summary

This study is testing a new saliva-based DNA test called i4i PRODICT® that estimates a man's future risk of prostate cancer. Researchers want to see if men from Black, South Asian, and White backgrounds are willing to take the test and find it acceptable. The goal is to enroll 1,000 men aged 40 to 55 to help improve early detection across different ethnic groups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust

    RECRUITING

    Sutton, Surrey, SM2 5PT, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The Royal Marsden Hospital

    RECRUITING

    London, SW3 6JJ, United Kingdom

    Contact Email: •••••@•••••

  • The Royal Marsden Hospital

    RECRUITING

    Sutton, SM2 5PT, United Kingdom

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.